Michael Kroeger

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results.

D. Lamm, K. Chamie, J. Gutheil, 2017, Urologic oncology.

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results.

D. Lamm, K. Chamie, J. Gutheil, 2017, Urologic oncology.